Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...

Quantum-Si recently announced its participation in the upcoming AGBT meeting, highlighting its advancements in Next-Generation Protein Sequencing, alongside establishing a Scientific Advisory ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, today ...

BRANFORD, Conn., March 13, 2025--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™, today announced that the Compensation ...

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the fourth ...

Jeff Hawkins; President and Chief Executive Officer; Quantum-Si Inc Jeff Keyes ... in the commercialization of our next generation protein sequencing technology and platinum instrument.

Quantum-Si incorporated (NASDAQ ... 2024 was an important year in the commercialization of our next-generation protein sequencing technology, the Platinum instrument. The year began with our ...

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is ...

Quantum-Si (NasdaqGM:QSI) recently announced its participation in the upcoming AGBT meeting, highlighting its advancements in Next-Generation Protein Sequencing, alongside establishing a Scientific ...